| GENE_SYMBOL |
DRUG_NAME |
Ki (nM) |
IC50 (nM) |
Kd (nM) |
EC50 (nM) |
Potency (nM) |
AC50 (nM) |
Datasource |
| LGALS3 |
triethylazanium (2R,3S,4S,5S,6R)-5-hydroxy-6-(hydroxymethyl)-2-methoxy-4-[(4-methylphenyl)carbonyloxy]oxan-3-yl (4-methylphenyl)methyl phosphate |
NA |
NA |
2500000 |
NA |
NA |
NA |
BindingDB |
| LGALS3 |
triethylammonium (2R,3S,4S,5S,6R)-5-hydroxy-6-(hydroxymethyl)-2-methoxy-4-(4-methylbenzoyloxy)-tetrahydro-2H-pyran-3-yl methyl phosphate |
NA |
NA |
600000 |
NA |
NA |
NA |
BindingDB |
| LGALS3 |
Methyl beta-galactoside |
NA |
NA |
4100000|4400000 |
NA |
NA |
NA |
BindingDB |
| LGALS4 |
Thiodigalactoside |
NA |
NA |
410000|980000|1450000 |
NA |
NA |
NA |
BindingDB |
| LGALS4 |
(2R,3R,4S,5R,6R)-2-(hydroxymethyl)-6-methoxy-4-(3-methoxyanilino)oxane-3,5-diol |
NA |
NA |
2400000|3100000 |
NA |
NA |
NA |
BindingDB |
| LGALS4 |
(2R,3R,4S,5R,6R)-4-(3,4-difluoroanilino)-2-(hydroxymethyl)-6-methoxyoxane-3,5-diol |
NA |
NA |
1800000 |
NA |
NA |
NA |
BindingDB |
| LGALS4 |
(2R,3R,4S,5R,6R)-2-(hydroxymethyl)-6-methoxy-4-(4-methoxyanilino)oxane-3,5-diol |
NA |
NA |
1200000|1300000 |
NA |
NA |
NA |
BindingDB |
| LGALS4 |
(2R,3R,4S,5R,6R)-2-(hydroxymethyl)-6-methoxy-4-(3-methylanilino)oxane-3,5-diol |
NA |
NA |
1000000 |
NA |
NA |
NA |
BindingDB |
| LGALS4 |
(2R,3R,4S,5R,6R)-2-(hydroxymethyl)-6-methoxy-4-(4-methylanilino)oxane-3,5-diol |
NA |
NA |
2300000 |
NA |
NA |
NA |
BindingDB |
| LGALS4 |
(2R,3R,4S,5R,6R)-4-(3-chloroanilino)-2-(hydroxymethyl)-6-methoxyoxane-3,5-diol |
NA |
NA |
1400000|1800000 |
NA |
NA |
NA |
BindingDB |
| LGALS4 |
Galectin-8-IN-1 |
NA |
NA |
1400000|1700000 |
NA |
NA |
NA |
BindingDB |
| LGALS4 |
2-[[(2~{R},3~{R},4~{R})-2-(hydroxymethyl)-3-oxidanyl-3,4-dihydro-2~{H}-pyran-4-yl]oxymethyl]quinoline-7-carboxylic acid |
NA |
NA |
2800000 |
NA |
NA |
NA |
BindingDB |
| LGALS4 |
methyl 3-O-(4-methylbenzoyl)-2-O-(2-nitrobenzoyl)-beta-D-talopyranoside |
NA |
NA |
440000 |
NA |
NA |
NA |
BindingDB |
| LGALS4 |
Galectin-3 antagonist 1 |
NA |
NA |
250000 |
NA |
NA |
NA |
BindingDB |
| LGALS4 |
methyl 2-O-(4-fluoro-2-nitrobenzoyl)-3-O-(4-methylbenzoyl)-beta-D-talopyranoside |
NA |
NA |
710000 |
NA |
NA |
NA |
BindingDB |
| LGALS4 |
methyl 3-O-(4-methylbenzoyl)-2-O-[2-nitro-4-(trifluoromethyl)benzoyl]-beta-D-talopyranoside |
NA |
NA |
1400000 |
NA |
NA |
NA |
BindingDB |
| LGALS4 |
methyl 3-O-(4-methylbenzoyl)-2-O-(3-nitrobenzoyl)-beta-D-talopyranoside |
NA |
NA |
630000|1400000 |
NA |
NA |
NA |
BindingDB |
| LGALS4 |
methyl 2-[[(2R,3R,4R)-3-hydroxy-2-(hydroxymethyl)-3,4-dihydro-2H-pyran-4-yl]oxymethyl]-3-methylbenzimidazole-5-carboxylate |
NA |
NA |
1700000|2600000 |
NA |
NA |
NA |
BindingDB |
| LGALS4 |
methyl 2-[[(2R,3R,4R)-3-hydroxy-2-(hydroxymethyl)-3,4-dihydro-2H-pyran-4-yl]oxymethyl]-3H-benzimidazole-5-carboxylate |
NA |
NA |
2500000|3200000 |
NA |
NA |
NA |
BindingDB |
| LGALS4 |
Galectin-8N-IN-1 |
NA |
NA |
120000|130000 |
NA |
NA |
NA |
BindingDB |